Blog & News
ROGER EXPLORES… the evolution of clinical trials (Part Two)
While great advances are made in the field of clinical trials, there are still considerable bottlenecks for sarcoma patients to participate in studies. Yet, new approaches may help. Roger Wilson takes a closer look for us.
Read MoreFDA approves pimicotinib for symptomatic tenosynovial giant cell tumor
A new milestone in the treatment of tenosynovial giant cell tumour (TGCT): the US Food and Drug Administration (FDA) has approved pimicotinib (Pimjetmi) for adults with symptomatic TGCT for whom surgery may cause worsening functional limitations or severe complications. The approval, announced on 10 November 2026, marks an important development for the TGCT community and…
Read MoreOne goal, many solutions: A patient’s view on ISOLS
Participating at an international congress on limb-saving surgery was overwhelming yet eye-opening for Stéphanie Anzellotti. She is a patient advocate at Cum Cura in Belgium and mother of a child who suffers from osteosarcoma. Stéphanie shares what she is taking home as her key learnings from this experts’ meeting.
Read MoreROGER EXPLORES… the evolution of clinical trials
Exciting progress is made in the field of clinical trials, finds Roger Wilson. He has participated in several exercises of clinical trial design as a patient advocate. Roger explains the what’s what of the latest developments.
Read MorePatient pathways must improve in Bulgaria – First national campaign on sarcoma shows how
The bitter experience of not finding the information they needed when their son was diagnosed with osteosarcoma, made Lidiya Vitanova and her husband give a promise: No family in Bulgaria should navigate sarcoma alone. They founded Together Fighting Sarcoma and pulled off a national campaign which won the third place of SPAGN’s Advocacy in Action Awards.
Read MoreEvery patient matters: Building the future of synovial sarcoma research
This year’s winner of the first prize of SPAGN’s Advocacy in Action Awards is the Synovial Sarcoma Foundation based in the US. With a mission to advance research into this rare and aggressive cancer, they established a biorepository and registry to gather patient data. Synovial sarcoma patients worldwide can participate in this game-changing program. Julie Kramer, a synovial sarcoma survivor herself, gives us the background.
Read MoreFrom listening to action: Patients’ voices are shaping sarcoma care in Italy
Concrete improvements in sarcoma care in Italy are becoming a reality. The country’s first Sarcoma White Paper maps out 14 recommendations based on patients’ priorities, and its implementation has already begun. The Fondazione Paola Gonzato-Rete Sarcoma ETS, founded by Ornella Gonzato, was honored for this landmark initiative last May by SPAGN with an Advocacy in Action Award. Martina Gherlinzoni, a member of the Foundation’s Board of Directors, explains what makes their project so distinctive that it has become a major national news story in Italy.
Read MoreSPAGN Annual Conference 2026 Highlights ✨
Photos: Uli Deck A Global Community United by Hope and Collaboration The SPAGN Annual Conference 2026, held in Stockholm, Sweden at Karolinska University Hospital and Elite Hotel Carolina Tower, once again demonstrated the strength, warmth, and determination of the global sarcoma community. Bringing together patients, advocates, healthcare professionals, researchers, and industry partners from around the…
Read MoreBy bike from Berlin to the Taj Mahal: Young Ewing sarcoma survivor starts charity tour
At the age of 22, John Müller was diagnosed with an Ewing sarcoma, followed by ten months of multimodal therapy. Three years later, he plans to set off by bicycle from Germany to India. His goal: to raise awareness of Ewing sarcomas and to mobilize donations for an emergency fund for sarcoma patients, particularly adolescents and young adults (AYA). Shortly before the start of his journey, John spoke with Voices of Sarcoma.
Read MoreROGER EXPLORES… Immunotherapy
Immunotherapy has transformed cancer treatment in recent years by harnessing the body’s own immune system to identify and fight tumour cells. But, its application in the treatment of sarcomas is still limited. Roger Wilson explains here some basics of immunotherapy, the implications for sarcoma patients and points to some studies. A Beginners’ guide on immunotherapy for sarcoma patients.
Read More